Literature DB >> 26096175

PRDM1, a Tumor-Suppressor Gene, is Induced by Genkwadaphnin in Human Colon Cancer SW620 Cells.

Ho-Bum Kang1, Ha-Reum Lee1, Da Jung Jee1, Su-Hyun Shin1,2, Seong-Su Nah3, Sun Young Yoon4, Jae Wha Kim1.   

Abstract

Genkwadaphnin (GD-1) is isolated from the flower buds of Daphne genkwa Siebold et Zuccarini (Thymelaeaceae), and it has been used as a traditional Korean and Chinese medicine. In this study, the authors observe that GD-1 inhibits the growth of the colon cancer cell line, SW620, through the up-regulation of p21 expression in a PRDM1-dependent manner. After treatment with GD-1, the transcriptional repressor PRDM1 is prominently induced in SW620 cells. Furthermore, GD-1 induce the phosphorylation of PKD1 and MEK and subsequently provide PRDM1 enhancement, resulting in the suppression of c-Myc expression and the up-regulation of p21. PKD1 knockdown using siRNA abrogates PRDM1 expression by GD-1 and subsequently disrupts the regulation of c-Myc and p21 expression. Treating SW620 cells with GD-1 inhibits cell-cycle progression and is characterized by the down-regulation of c-Myc followed by the up-regulation of p21 expression. The up-regulation of p21 by GD-1 induces the growth arrest of the SW620 colon cancer cell line. Based on these data, the authors propose that GD-1 has tumor-suppressor activity that may contribute to the anti-tumor effects of PRDM1 in colon cancer.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  GENKWADAPHNIN (GD-1); PKD1; PRDM1

Mesh:

Substances:

Year:  2016        PMID: 26096175     DOI: 10.1002/jcb.25262

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

3.  MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1.

Authors:  Bao Chai; Yarong Guo; Xiangli Cui; Jinchun Liu; Yuhong Suo; Zhangfeng Dou; Ning Li
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

4.  PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids.

Authors:  Changlong Liu; Carolyn E Banister; Charles C Weige; Diego Altomare; Joseph H Richardson; Carlo M Contreras; Phillip J Buckhaults
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

5.  Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.

Authors:  Sapan J Patel; Su Dao; Costel C Darie; Bayard D Clarkson
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

6.  Prognostic cancer gene signatures share common regulatory motifs.

Authors:  Ying Wang; Steve Goodison; Xiaoman Li; Haiyan Hu
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

7.  Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.

Authors:  Aditya Ganju; Subhash C Chauhan; Bilal Bin Hafeez; Kyle Doxtater; Manish K Tripathi; Nadeem Zafar; Murali M Yallapu; Rakesh Kumar; Meena Jaggi
Journal:  Br J Cancer       Date:  2018-02-20       Impact factor: 7.640

Review 8.  Phytochemistry and Pharmacological Activities of the Diterpenoids from the Genus Daphne.

Authors:  Yi-Wen Nie; Yuan Li; Lan Luo; Chun-Yan Zhang; Wei Fan; Wei-Ying Gu; Kou-Rong Shi; Xiao-Xiang Zhai; Jian-Yong Zhu
Journal:  Molecules       Date:  2021-10-31       Impact factor: 4.411

9.  Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.

Authors:  Jie Wu; Ling Guo; Xiaoran Qiu; Yong Ren; Feifei Li; Wei Cui; Shaojiang Song
Journal:  Br J Cancer       Date:  2020-09-22       Impact factor: 7.640

10.  Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.

Authors:  Raquel Romero-García; Laura Gómez-Jaramillo; Rosa María Mateos; Gema Jiménez-Gómez; Nuria Pedreño-Horrillo; Esther Foncubierta; Juan Francisco Rodríguez-Gutiérrez; Sebastián Garzón; Francisco Mora-López; Carmen Rodríguez; Luis M Valor; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.